The Promise of the Dual Prevention Pill: A Framework for Development and Introduction

Women of reproductive age need multipurpose prevention technology (MPT) products to address two overlapping health risks: unintended pregnancy and HIV. Currently, condoms are the only available MPT, however male condoms are not within the control of a woman, and the use of female condoms has been li...

Full description

Bibliographic Details
Main Authors: Barbara A. Friedland, Sanyukta Mathur, Lisa B. Haddad
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Reproductive Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frph.2021.682689/full
id doaj-025e17d8bb6745079a3c1895cbecc96d
record_format Article
spelling doaj-025e17d8bb6745079a3c1895cbecc96d2021-06-23T04:23:37ZengFrontiers Media S.A.Frontiers in Reproductive Health2673-31532021-06-01310.3389/frph.2021.682689682689The Promise of the Dual Prevention Pill: A Framework for Development and IntroductionBarbara A. Friedland0Sanyukta Mathur1Lisa B. Haddad2Population Council, Center for Biomedical Research, New York, NY, United StatesPopulation Council, HIV and AIDS Program, Washington, DC, United StatesPopulation Council, Center for Biomedical Research, New York, NY, United StatesWomen of reproductive age need multipurpose prevention technology (MPT) products to address two overlapping health risks: unintended pregnancy and HIV. Currently, condoms are the only available MPT, however male condoms are not within the control of a woman, and the use of female condoms has been limited by low acceptability and cost. Oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, yet uptake and adherence among women have been low to date. Women globally need more options for HIV and pregnancy prevention. Several MPTs for simultaneous HIV and pregnancy prevention are in various stages of development and clinical testing, although most are many years away from market launch. A dual prevention pill (DPP), a daily oral pill combining oral contraceptives and PrEP, both of which are licensed, approved products in many low- and middle-income countries (LMIC), is likely to be the fastest route to getting an MPT product into the hands of women. The DPP is one option that could enhance method choice, particularly for women who are already using oral contraceptives. By leveraging the oral contraceptive market and reaching women currently using condoms or with an unmet need for contraception, the DPP has the potential to increase the uptake of PrEP. The successful rollout of the DPP will require careful consideration of user-, provider-, and product-centered factors during product development and introduction. Early attention to these interrelated factors can help ensure that the DPP has the ideal characteristics for maximum product acceptability, that effective and quality services are designed and implemented, and that users can make informed choices, demand the product, and use it effectively. The proposed framework outlines key considerations for the effective development and introduction of the DPP, which could also facilitate integration models for future MPTs.https://www.frontiersin.org/articles/10.3389/frph.2021.682689/fullHIV preventionmultipurpose prevention technologiesPrEP-FP integrationintegrated healthcareoral contraceptivesPrEP
collection DOAJ
language English
format Article
sources DOAJ
author Barbara A. Friedland
Sanyukta Mathur
Lisa B. Haddad
spellingShingle Barbara A. Friedland
Sanyukta Mathur
Lisa B. Haddad
The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
Frontiers in Reproductive Health
HIV prevention
multipurpose prevention technologies
PrEP-FP integration
integrated healthcare
oral contraceptives
PrEP
author_facet Barbara A. Friedland
Sanyukta Mathur
Lisa B. Haddad
author_sort Barbara A. Friedland
title The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
title_short The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
title_full The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
title_fullStr The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
title_full_unstemmed The Promise of the Dual Prevention Pill: A Framework for Development and Introduction
title_sort promise of the dual prevention pill: a framework for development and introduction
publisher Frontiers Media S.A.
series Frontiers in Reproductive Health
issn 2673-3153
publishDate 2021-06-01
description Women of reproductive age need multipurpose prevention technology (MPT) products to address two overlapping health risks: unintended pregnancy and HIV. Currently, condoms are the only available MPT, however male condoms are not within the control of a woman, and the use of female condoms has been limited by low acceptability and cost. Oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, yet uptake and adherence among women have been low to date. Women globally need more options for HIV and pregnancy prevention. Several MPTs for simultaneous HIV and pregnancy prevention are in various stages of development and clinical testing, although most are many years away from market launch. A dual prevention pill (DPP), a daily oral pill combining oral contraceptives and PrEP, both of which are licensed, approved products in many low- and middle-income countries (LMIC), is likely to be the fastest route to getting an MPT product into the hands of women. The DPP is one option that could enhance method choice, particularly for women who are already using oral contraceptives. By leveraging the oral contraceptive market and reaching women currently using condoms or with an unmet need for contraception, the DPP has the potential to increase the uptake of PrEP. The successful rollout of the DPP will require careful consideration of user-, provider-, and product-centered factors during product development and introduction. Early attention to these interrelated factors can help ensure that the DPP has the ideal characteristics for maximum product acceptability, that effective and quality services are designed and implemented, and that users can make informed choices, demand the product, and use it effectively. The proposed framework outlines key considerations for the effective development and introduction of the DPP, which could also facilitate integration models for future MPTs.
topic HIV prevention
multipurpose prevention technologies
PrEP-FP integration
integrated healthcare
oral contraceptives
PrEP
url https://www.frontiersin.org/articles/10.3389/frph.2021.682689/full
work_keys_str_mv AT barbaraafriedland thepromiseofthedualpreventionpillaframeworkfordevelopmentandintroduction
AT sanyuktamathur thepromiseofthedualpreventionpillaframeworkfordevelopmentandintroduction
AT lisabhaddad thepromiseofthedualpreventionpillaframeworkfordevelopmentandintroduction
AT barbaraafriedland promiseofthedualpreventionpillaframeworkfordevelopmentandintroduction
AT sanyuktamathur promiseofthedualpreventionpillaframeworkfordevelopmentandintroduction
AT lisabhaddad promiseofthedualpreventionpillaframeworkfordevelopmentandintroduction
_version_ 1721362561792737280